American Clinical Solutions is a biotechnology and healthcare startup founded in 2008. The company specializes in providing advanced urine drug confirmation services to medical facilities and healthcare providers. Utilizing cutting-edge equipment, American Clinical Solutions ensures precise testing for both prescription and illicit narcotics. Their exclusive testing method enhances detection capabilities and accuracy, enabling healthcare providers to prescribe with confidence and monitor the effectiveness of prescription regimens. The startup received a $10.00M Debt Financing investment on 23 June 2015 from Capitala Group. This investment has supported the company in further developing and refining their approaches to meet or surpass the latest testing standards. The feedback from physician colleagues plays a crucial role in ensuring the highest quality testing results and reporting services. With a strong focus on patient health and safety, American Clinical Solutions continues to optimize the benefits of prescription medications and promote better patient outcomes.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Debt Financing | $10.00M | 1 |
|
23 Jun 2015 |
No recent news or press coverage available for American Clinical Solutions (ACS).
We care about your data, and we'd love to use cookies make your experience better.
